Results 11 to 20 of about 695,469 (357)
The genetics of interstitial lung diseases [PDF]
European Respiratory Review, 2019 Interstitial lung diseases (ILDs) are a set of heterogeneous lung diseases characterised by inflammation and, in some cases, fibrosis. These lung conditions lead to dyspnoea, cough, abnormalities in gas exchange, restrictive physiology (characterised by ...
Raphaël Borie +7 more
semanticscholar +4 more sources
Comorbidities in interstitial lung diseases [PDF]
European Respiratory Review, 2017 Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted.
G. Margaritopoulos +2 more
semanticscholar +4 more sources
Telomeres in Interstitial Lung Disease [PDF]
Journal of Clinical Medicine, 2021 Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division, telomeres shorten, but the telomerase complex partially counteracts progressive loss of telomeres ...
Stock, C, Renzoni, E
openaire +4 more sources
Lung transplantation for interstitial lung disease [PDF]
European Respiratory Review, 2021 Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire +3 more sources
Interstitial lung disease [PDF]
European Respiratory Review, 2014 Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M. +5 more
openaire +4 more sources
Journal of Nuclear Medicine, 2021 Visual Abstract Interstitial lung diseases (ILDs) comprise over 200 parenchymal lung disorders. Among them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor prognosis, whereas some other ILDs, such as sarcoidosis, have
M. Röhrich +15 more
semanticscholar +1 more source
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Drugs, 2021 Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological processes, indicating the potential for common approaches to treatment.
Yvette N. Lamb
semanticscholar +1 more source
BMC Pulmonary Medicine, 2021 Background Silicosis is a progressive pneumoconiosis characterized by interstitial fibrosis following exposure to silica dust. The role of metabolic dysregulation in the pathogenesis of silicosis has not been investigated in detail.
Changjiang Xue +4 more
doaj +1 more source
The prevalence and burden of interstitial lung diseases in the USA
ERJ Open Research, 2021 Interstitial lung diseases (ILDs) are a heterogeneous group of diseases (i.e. idiopathic interstitial pneumonias, autoimmune ILDs, environmental exposure-related ILDs, sarcoidosis) but share several common clinical and pathophysiological features [1, 2].
N. Jeganathan, Matheni Sathananthan
semanticscholar +1 more source
Cluster features in fibrosing interstitial lung disease and associations with prognosis
BMC Pulmonary Medicine, 2023 Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management.
Yuanying Wang +5 more
doaj +1 more source